These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 18305454)

  • 21. Federal drug agency gets flack about human subjects protections in clinical trials.
    Beckman M
    J Natl Cancer Inst; 2008 Jan; 100(2):90-1. PubMed ID: 18182612
    [No Abstract]   [Full Text] [Related]  

  • 22. [ICH-GCP Guideline: quality assurance of clinical trials. Status and perspectives].
    Englev E; Petersen KP
    Ugeskr Laeger; 2003 Apr; 165(16):1659-62. PubMed ID: 12756823
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Research ethics committees and conflicts of interest.
    Price L
    Bull Med Ethics; 2003 Sep; (191):13-6. PubMed ID: 16206440
    [No Abstract]   [Full Text] [Related]  

  • 24. Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke.
    Higashida RT; Furlan AJ; Roberts H; Tomsick T; Connors B; Barr J; Dillon W; Warach S; Broderick J; Tilley B; Sacks D; ;
    Stroke; 2003 Aug; 34(8):e109-37. PubMed ID: 12869717
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bioethical malpractice: risk and responsibilities in human research.
    Noah BA
    J Health Care Law Policy; 2004; 7(2):175-241. PubMed ID: 15573441
    [No Abstract]   [Full Text] [Related]  

  • 26. Is mandatory research ethics reviewing ethical?
    Dyck M; Allen G
    J Med Ethics; 2013 Aug; 39(8):517-20. PubMed ID: 22865925
    [TBL] [Abstract][Full Text] [Related]  

  • 27. US clinical-research system in need of review.
    Ammann AJ
    Nature; 2013 Jun; 498(7452):7. PubMed ID: 23739388
    [No Abstract]   [Full Text] [Related]  

  • 28. Ethical oversight of research on patient care.
    Solomon MZ; Bonham AC
    Hastings Cent Rep; 2013; Spec No():S2-3. PubMed ID: 23315889
    [No Abstract]   [Full Text] [Related]  

  • 29. Response to open peer commentaries on "Social contexts influence ethical considerations of research".
    Levine RJ; Gordon JB; Mazure CM; Rubin PE; Schaller BR; Young JL
    Am J Bioeth; 2011 May; 11(5):W1-2. PubMed ID: 21534134
    [No Abstract]   [Full Text] [Related]  

  • 30. Proxy and surrogate consent in geriatric neuropsychiatric research: update and recommendations.
    Kim SY; Appelbaum PS; Jeste DV; Olin JT
    Am J Psychiatry; 2004 May; 161(5):797-806. PubMed ID: 15121642
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Conflict of interest in human subjects research.
    Groeger JS; Barnes M
    Crit Care Med; 2003 Mar; 31(3 Suppl):S137-42. PubMed ID: 12626959
    [No Abstract]   [Full Text] [Related]  

  • 32. Duke's hazards. Did medical experiments put patients needlessly at risk?
    Kaplan S; Brownlee S
    US News World Rep; 1999 May; 126(20):66-8, 70. PubMed ID: 10387890
    [No Abstract]   [Full Text] [Related]  

  • 33. Ethical issues arising from medical research.
    Hamilton MP
    Isr J Med Sci; 1983 May; 19(5):431-6. PubMed ID: 6345463
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The impact of escalating regulatory requirements on the conduct of clinical research.
    Gordon BG; Kessinger A; Mann SL; Prentice ED
    Cytotherapy; 2003; 5(4):309-13. PubMed ID: 12944237
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Researchers' ethical duties are not to be outsourced.
    Glantz LH
    Nature; 2007 Sep; 449(7159):139. PubMed ID: 17851492
    [No Abstract]   [Full Text] [Related]  

  • 36. Bioethics. Researchers attack newspaper probe of trials.
    Kaiser J
    Science; 2006 Sep; 313(5794):1714. PubMed ID: 16990521
    [No Abstract]   [Full Text] [Related]  

  • 37. Toward protecting the safety of participants in clinical trials.
    Califf RM; Morse MA; Wittes J; Goodman SN; Nelson DK; DeMets DL; Iafrate RP; Sugarman J
    Control Clin Trials; 2003 Jun; 24(3):256-71. PubMed ID: 12757992
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Some thoughts on the reporting of adverse events in phase II cancer clinical trials.
    Anderson SJ
    J Clin Oncol; 2006 Aug; 24(24):3821-2. PubMed ID: 16921032
    [No Abstract]   [Full Text] [Related]  

  • 39. Overhaul of NCI Clinical Trial System Still in Progress.
    Nicholas J
    J Natl Cancer Inst; 2013 Aug; 105(15):1067-8. PubMed ID: 23884052
    [No Abstract]   [Full Text] [Related]  

  • 40. Can underpowered clinical trials be justified?
    Rosoff PM
    IRB; 2004; 26(3):16-9. PubMed ID: 15281196
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.